Columbia Laboratories Inc.  

(Public, NASDAQ:CBRX)   Watch this stock  
Find more results for Valerie D. Jones�
6.35
+0.11 (1.76%)
Jul 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 6.09 - 6.38
52 week 5.20 - 8.37
Open 6.18
Vol / Avg. 78,030.00/35,121.00
Mkt cap 68.32M
P/E 12.60
Div/yield     -
EPS 0.50
Shares 10.76M
Beta 0.71
Inst. own 18%
Aug 4, 2014
Q2 2014 Columbia Laboratories Earnings Release (Estimated) Add to calendar
May 8, 2014
Columbia Laboratories Annual Shareholder Meeting
Apr 29, 2014
Q1 2014 Columbia Laboratories Earnings Release
Apr 29, 2014
Q1 2014 Columbia Laboratories Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 5.92% 22.94%
Operating margin 1.71% 20.10%
EBITD margin - 28.80%
Return on average assets 3.08% 13.83%
Return on average equity 3.93% 17.07%
Employees 77 -
CDP Score - -

Address

4TH FLOOR, 4 LIBERTY SQUARE
BOSTON, MA 2109
United States - Map
+1-973-4868820 (Phone)
+1-617-4820618 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Columbia Laboratories, Inc. (Columbia) is engaged in pharmaceutical development. The Company has developed and brought to market six bioadhesive products, each commercialized through alliances. The Company�s product, CRINONE (progesterone gel), is sold by Actavis in the United States and by Merck Serono in over 60 other countries worldwide. In September 2013, Columbia acquired Molecular Profiles, a CDMO. Through Molecular Profiles, the Company offers formulation, development, manufacturing and analytics capabilities to clients, including multi-national pharmaceutical companies, specialized drug-delivery firms and biotechnology companies.

Officers and directors

Stephen Garfield Kasnet Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Frank C. Condella Jr. President, Chief Executive Officer, Director
Age: 59
Bio & Compensation  - Reuters
Jonathan B. Lloyd Jones Chief Financial Officer, Vice President, Treasurer, Secretary
Age: 53
Bio & Compensation  - Reuters
Donald H. Hunter Director
Age: 58
Bio & Compensation  - Reuters
Nikin Patel Director
Age: 41
Bio & Compensation  - Reuters
Valerie L. Andrews Independent Director
Age: 54
Bio & Compensation  - Reuters
Frank Murdoch Armstrong Independent Director
Age: 56
Bio & Compensation  - Reuters
Cristina Csimma Pharm.D., M.H.P. Independent Director
Age: 55
Bio & Compensation  - Reuters